GenoLogics Completes Additional Financing to Accelerate Translational Research Informatics Growth
News Feb 27, 2009
GenoLogics has announced it has completed $5 million in financing, which will be applied towards ongoing expansion plans.
The latest round of financing was led by OVP Venture Partners of Seattle with support from Growth Works and Yaletown Venture Partners of Vancouver. The funds will be used to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.
“We feel positive that the growth GenoLogics has experienced will continue as they expand their footprint in the life sciences software market,” said Chad Waite, Managing Director at OVP Venture Partners. “We’ve already seen GenoLogics make significant inroads by establishing collaborative partnerships with leading organizations that are looking for ways to achieve their translational research outcomes.”
Last year GenoLogics announced a new product suite for biorepositories and biomedical informatics to help customers better manage their clinical information. GenoLogics has developed this product suite in collaboration with the Fred Hutchinson Cancer Center, Windber Research Institute and the University of Texas Medical Branch. When the biomedical products are deployed in combination with the GenoLogics’ research informatics solutions, clients have a comprehensive bench-to-bedside informatics platform to enable their translational research initiatives.
“Over the past year we’ve invested in enhancing the capabilities our informatics platform to integrate data from both the clinical and research domains, providing our clients with an end-to-end translational research solution,” said Michael Ball, CEO for GenoLogics. “The additional funding will allow us to accelerate deployment of our biomedical informatics product suite, as well as expand our sales and support infrastructure to sustain the rapid increase we are seeing in customer adoption.”
Algorithm Predicts Life Expectancy After Heart AttackNews
A new algorithm developed by UCLA researchers more accurately predicts which people will survive heart failure, and for how long, whether or not they receive a heart transplant. The algorithm would allow doctors to make more personalized assessments of people who are awaiting heart transplants, which in turn could enable health care providers to make better use of limited life-saving resources and potentially reduce health care costs.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
4000-Year Old DNA Helps Track the Spread of Rice Farming in AsiaNews
Rice farming spread far and wide in ancient Southeast Asia, but how it got there has been a mystery. Now, a study of 4000-year-old DNA—a rare find in this region—suggests it came with farmers migrating from China, where rice farming originated.